Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Alzheimer's and Parkinson's diseases: an environmental proteomic point of view

Demartini DR, Schilling LP, da Costa JC, Carlini CR.

J Proteomics. 2014 Jun 2;104:24-36. doi: 10.1016/j.jprot.2014.04.014. Epub 2014 Apr 18.

Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders

Forlenza OV, De-Paula VJ, Diniz BS.

ACS Chem Neurosci. 2014 Jun 18;5(6):443-50. doi: 10.1021/cn5000309. Epub 2014 May 6.

Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology

Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C, Sabbagh M, Villa S, Tembe W, Craig D, Van Keuren-Jensen K.

PLoS One. 2014 May 5;9(5):e94839. doi: 10.1371/journal.pone.0094839. eCollection 2014.

Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature

Tang W, Huang Q, Yao YY, Wang Y, Wu YL, Wang ZY.

J Neural Transm (Vienna). 2014 Dec;121(12):1541-53. doi: 10.1007/s00702-014-1226-y. Epub 2014 May 10.

Computer-assisted system for diagnosing degenerative dementia using cerebral blood flow SPECT and 3D-SSP: a multicenter study

Ishii K, Ito K, Nakanishi A, Kitamura S, Terashima A.

Jpn J Radiol. 2014 Jul;32(7):383-90. doi: 10.1007/s11604-014-0329-6. Epub 2014 May 17.

Cerebrospinal fluid levels of a 20-22 kDa NH2 fragment of human tau provide a novel neuronal injury biomarker in Alzheimer's disease and other dementias

Amadoro G, Corsetti V, Sancesario GM, Lubrano A, Melchiorri G, Bernardini S, Calissano P, Sancesario G.

J Alzheimers Dis. 2014;42(1):211-26. doi: 10.3233/JAD-140267.

Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease

Xie A, Gao J, Xu L, Meng D.

Biomed Res Int. 2014;2014:648740. doi: 10.1155/2014/648740. Epub 2014 May 12.

The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk

Tanner CM, Goldman SM, Ross GW, Grate SJ.

Alzheimers Dement. 2014 Jun;10(3 Suppl):S213-25. doi: 10.1016/j.jalz.2014.04.014.

Creativity and neurological disease

Acosta LM.

Curr Neurol Neurosci Rep. 2014 Aug;14(8):464. doi: 10.1007/s11910-014-0464-6.

Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases

Stelmashook EV, Isaev NK, Genrikhs EE, Amelkina GA, Khaspekov LG, Skrebitsky VG, Illarioshkin SN.

Biochemistry (Mosc). 2014 May;79(5):391-6. doi: 10.1134/S0006297914050022.

Novel drug delivery systems for releasing growth factors to the CNS: focus on Alzheimer's and Parkinson's diseases

Herran E, Igartua M, Pedraz JL, Hernandez RM.

Mini Rev Med Chem. 2014;14(7):557-66. doi: 10.2174/1389557514666140622205058.

Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies

Broadstock M, Ballard C, Corbett A.

Expert Opin Pharmacother. 2014 Sep;15(13):1797-810. doi: 10.1517/14656566.2014.936848. Epub 2014 Jul 3.

Vitamin D receptor polymorphisms and susceptibility to Parkinson's disease and Alzheimer's disease: a meta-analysis

Lee YH, Kim JH, Song GG.

Neurol Sci. 2014 Dec;35(12):1947-53. doi: 10.1007/s10072-014-1868-4. Epub 2014 Jul 10.

Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues

O'Bryant SE, Xiao G, Zhang F, Edwards M, German DC, Yin X, Como T, Reisch J, Huebinger RM, Graff-Radford N, Dickson D, Barber R, Hall J, O'Suilleabhain P, Grammas P.

J Alzheimers Dis. 2014;42(4):1325-35. doi: 10.3233/JAD-141041.

Lewy body compared with Alzheimer dementia is associated with decreased functional connectivity in resting state networks

Lowther ER, O'Brien JT, Firbank MJ, Blamire AM.

Psychiatry Res. 2014 Sep 30;223(3):192-201. doi: 10.1016/j.pscychresns.2014.06.004. Epub 2014 Jun 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias